...
clsd-img

Clearside Biomedical Inc, Common Stock

CLSD

NMQ

$0.95

+$0.02

(2.15%)

1D
Industry: Pharmaceuticals Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$70.46M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
179.57K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
2.33
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.8 L
$2.12 H
$0.95

About Clearside Biomedical Inc, Common Stock

Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. It offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injectable suspension for suprachoroidal injection, which is in Phase IIb clinical trial to treat wet AMD. The company has a collaboration with Bausch Health, Arctic Vision, REGENXBIO, Inc., BioCryst Pharmaceuticals, Inc., and Aura Biosciences. Clearside Biomedical, Inc. was incorporated in 2011 and is headquartered in Alpharetta, Georgia. more

Industry: PharmaceuticalsSector: Health Care

Returns

Time FrameCLSDSectorS&P500
1-Week Return8.91%0.69%1.43%
1-Month Return-11.21%-5.44%0.41%
3-Month Return-18.1%-9.19%5.22%
6-Month Return-25.78%-4.74%9.72%
1-Year Return-19.49%2.25%26.24%
3-Year Return-66.07%-1.29%25.98%
5-Year Return-69.75%34.98%86.34%
10-Year Return-86.9%100.3%188.79%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue2.17M7.89M29.57M1.33M8.23M[{"date":"2019-12-31","value":7.35,"profit":true},{"date":"2020-12-31","value":26.69,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":4.49,"profit":true},{"date":"2023-12-31","value":27.81,"profit":true}]
Cost of Revenue--178.00K204.00K355.00K[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":50.14,"profit":true},{"date":"2022-12-31","value":57.46,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Profit2.17M7.89M29.40M1.12M7.87M[{"date":"2019-12-31","value":7.39,"profit":true},{"date":"2020-12-31","value":26.85,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":3.82,"profit":true},{"date":"2023-12-31","value":26.77,"profit":true}]
Gross Margin100.00%100.00%99.40%84.63%95.68%[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":99.4,"profit":true},{"date":"2022-12-31","value":84.63,"profit":true},{"date":"2023-12-31","value":95.68,"profit":true}]
Operating Expenses32.48M25.83M30.20M31.40M32.72M[{"date":"2019-12-31","value":99.27,"profit":true},{"date":"2020-12-31","value":78.95,"profit":true},{"date":"2021-12-31","value":92.32,"profit":true},{"date":"2022-12-31","value":95.98,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income(30.30M)(17.93M)(627.00K)(30.28M)(24.84M)[{"date":"2019-12-31","value":-3030400000,"profit":false},{"date":"2020-12-31","value":-1793500000,"profit":false},{"date":"2021-12-31","value":-62700000,"profit":false},{"date":"2022-12-31","value":-3027700000,"profit":false},{"date":"2023-12-31","value":-2484400000,"profit":false}]
Total Non-Operating Income/Expense-(275.00K)1.00M(6.01M)(17.00M)[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-27.42,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-599.1,"profit":false},{"date":"2023-12-31","value":-1695.01,"profit":false}]
Pre-Tax Income(30.77M)(18.21M)376.00K(32.95M)(32.48M)[{"date":"2019-12-31","value":-8183.51,"profit":false},{"date":"2020-12-31","value":-4843.09,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-8762.5,"profit":false},{"date":"2023-12-31","value":-8639.63,"profit":false}]
Income Taxes(211.00K)(180.00K)(58.56K)1.12M(100.89K)[{"date":"2019-12-31","value":-18.77,"profit":false},{"date":"2020-12-31","value":-16.01,"profit":false},{"date":"2021-12-31","value":-5.21,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-8.97,"profit":false}]
Income After Taxes-(18.03M)434.56K(34.07M)(32.38M)[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-4149.04,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-7840.46,"profit":false},{"date":"2023-12-31","value":-7452.19,"profit":false}]
Income From Continuous Operations(30.77M)(18.21M)376.00K(29.61M)(32.48M)[{"date":"2019-12-31","value":-8183.51,"profit":false},{"date":"2020-12-31","value":-4843.09,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-7874.47,"profit":false},{"date":"2023-12-31","value":-8639.63,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(30.56M)(18.03M)376.00K(34.07M)(32.48M)[{"date":"2019-12-31","value":-8127.39,"profit":false},{"date":"2020-12-31","value":-4795.21,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-9061.53,"profit":false},{"date":"2023-12-31","value":-8639.63,"profit":false}]
EPS (Diluted)(0.91)(0.39)(0.01)(0.55)(0.53)[{"date":"2019-12-31","value":-91,"profit":false},{"date":"2020-12-31","value":-39,"profit":false},{"date":"2021-12-31","value":-1,"profit":false},{"date":"2022-12-31","value":-55,"profit":false},{"date":"2023-12-31","value":-53,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

CLSD
Cash Ratio 4.22
Current Ratio 4.49

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

CLSD
ROA (LTM) -44.05%
ROE (LTM) -1310.02%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

CLSD
Debt Ratio Lower is generally better. Negative is bad. 2.19
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. -1.19

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

CLSD
Trailing PE NM
Forward PE NM
P/S (TTM) 9.36
P/B 3.93
Price/FCF NM
EV/R 6.19
EV/Ebitda NM
PEG NM

FAQs

What is Clearside Biomedical Inc share price today?

Clearside Biomedical Inc (CLSD) share price today is $0.95

Can Indians buy Clearside Biomedical Inc shares?

Yes, Indians can buy shares of Clearside Biomedical Inc (CLSD) on Vested. To buy Clearside Biomedical Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in CLSD stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Clearside Biomedical Inc be purchased?

Yes, you can purchase fractional shares of Clearside Biomedical Inc (CLSD) via the Vested app. You can start investing in Clearside Biomedical Inc (CLSD) with a minimum investment of $1.

How to invest in Clearside Biomedical Inc shares from India?

You can invest in shares of Clearside Biomedical Inc (CLSD) via Vested in three simple steps:

  • Click on Sign Up or Invest in CLSD stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Clearside Biomedical Inc shares
What is Clearside Biomedical Inc 52-week high and low stock price?

The 52-week high price of Clearside Biomedical Inc (CLSD) is $2.12. The 52-week low price of Clearside Biomedical Inc (CLSD) is $0.8.

What is Clearside Biomedical Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Clearside Biomedical Inc (CLSD) is

What is Clearside Biomedical Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Clearside Biomedical Inc (CLSD) is 3.93

What is Clearside Biomedical Inc dividend yield?

The dividend yield of Clearside Biomedical Inc (CLSD) is 0.00%

What is the Market Cap of Clearside Biomedical Inc?

The market capitalization of Clearside Biomedical Inc (CLSD) is $70.46M

What is Clearside Biomedical Inc’s stock symbol?

The stock symbol (or ticker) of Clearside Biomedical Inc is CLSD

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top